Testing effectiveness (Phase 2)Ended earlyNCT00326872
What this trial is testing
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromaSpinal Cord Neurofibroma
National Cancer Institute (NCI) 26